Drug profile · INN
canakinumab
CANAKINUMAB NOVARTIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
canakinumab (CANAKINUMAB NOVARTIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN canakinumab
Brand CANAKINUMAB NOVARTIS
Route SUBCUTANEOUS
Formulation INJECTABLE
ATC code L04AC08
Frequently asked questions
What is canakinumab?
canakinumab (CANAKINUMAB NOVARTIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for canakinumab?
CANAKINUMAB NOVARTIS is a marketed brand name for canakinumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of canakinumab?
canakinumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.